[1]
2025. 755 Evolution of Functional and Paraclinical Markers as Predictive Factors in Pediatric Late-Onset SMA Under Nusinersen Treatment: The Role of CSF pNF-H. Balneo and PRM Research Journal. 15, 4 (Feb. 2025).